<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03615339</url>
  </required_header>
  <id_info>
    <org_study_id>799</org_study_id>
    <nct_id>NCT03615339</nct_id>
  </id_info>
  <brief_title>Pilot Trial Investigating Fermented Whey Supplementation in Healthy Adults</brief_title>
  <official_title>The Use of Fermented Whey Concentrate in Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aberdeen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>A. Vogel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aberdeen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pilot trial: 6-week single arm intervention. Healthy adults (male and female) consume
      Molkosan (fermented whey) twice a day (AM &amp; PM).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      MolkosanÂ® is made from fresh organic whey using a special fermentation process involving
      lactic acid producing bacteria (L+ lactic acid 70g/L). The company, A.Vogel (Roggwil,
      Switzerland) will provide the product and we will collect biological samples for analysis in
      a proof of concept study design that will provide preliminary data for future larger studies.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 16, 2015</start_date>
  <completion_date type="Actual">July 7, 2015</completion_date>
  <primary_completion_date type="Actual">July 7, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Unlabelled bottles of treatment</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in microbiota activity</measure>
    <time_frame>Baseline, day 21 and 42</time_frame>
    <description>Faecal short-chain fatty acids, measured by gas chromatography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in glucose tolerance (Oral glucose tolerance test (OGTT)</measure>
    <time_frame>Baseline, day 21 and 42</time_frame>
    <description>Six blood samples will be collected during the course of 3 hours (0, 30, 60, 90,120 and 180 min) using a cannulation after consuming 75 g of Polycal liquid (glucose load). Plasma glucose level and insulin are analysed as total area under the curve (AUC) and incremental AUC.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in microbiota composition - 16s rRNA (ribosomal ribonucleic acid) sequencing</measure>
    <time_frame>Baseline, day 21 and 42</time_frame>
    <description>16S rRNA extracted from fresh stool samples (&lt;16hrs)</description>
  </other_outcome>
  <other_outcome>
    <measure>Subjective assessment of digestion and bowel movements</measure>
    <time_frame>Baseline and day 14-18</time_frame>
    <description>Volunteer self-reported symptoms measured by questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Energy intake</measure>
    <time_frame>Baseline and day 14-18</time_frame>
    <description>4-day weighed food diary analysed for energy intake and macronutrient composition</description>
  </other_outcome>
  <other_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Screening, baseline and day 42</time_frame>
    <description>Repeated in triplicate, measured in mmHg</description>
  </other_outcome>
  <other_outcome>
    <measure>Pulse</measure>
    <time_frame>Screening, baseline and day 42</time_frame>
    <description>Triplicate measurement, expressed as beats per minute</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Molkosan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consumption of Molkosan (fermented whey) 20ml to be diluted in 200ml water prior to use twice a day (morning &amp; evening).
Total duration was 6 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Molkosan</intervention_name>
    <description>Twice daily (AM and PM) 20ml of fermented whey concentrate consumed diluted in 200ml water</description>
    <arm_group_label>Molkosan</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-65

          -  BMI 18-40 kg/m-2

        Exclusion Criteria:

          -  Diabetes

          -  Severe gastrointestinal disorders,

          -  Kidney disease,

          -  Thromboembolic or coagulation disease,

          -  Hepatic disease,

          -  Alcohol or any other substance abuse

          -  Gout

          -  Eating disorders

          -  Unregulated thyroid disease

          -  Dairy intolerance

          -  Antibiotic use within the last 3 months, including prescribed use

          -  Current prebiotic or prebiotic use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandra M Johnstone, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rowett Institute, University of Aberdeen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Rowett Institute, Human Nutrition Unit</name>
      <address>
        <city>Aberdeen</city>
        <zip>AB25 2ZD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://www.avogel.co.uk/food/products/molkosan-digestion/</url>
    <description>A. Vogel product website and description</description>
  </link>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>June 25, 2018</study_first_submitted>
  <study_first_submitted_qc>July 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2018</study_first_posted>
  <last_update_submitted>July 30, 2018</last_update_submitted>
  <last_update_submitted_qc>July 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Food supplement, Fermented food, Whey</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

